Association of C-reactive protein and homocysteine with subclinical coronary plaque subtype and stenosis using low-dose MDCT coronary angiography

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 501-506

  Lin, Tsann ^a,b   Liu, Juhn Cherng ^a,b   Chang, Li Ya ^b   Shen, Chien Wei ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Atherosclerosis; C reactive protein; Homocysteine; Multidetector computed tomography coronary angiography; Plaque; Stenosis

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL; WAIST CIRCUMFERENCE;

ADULT; AGED; C-REACTIVE PROTEIN; CONSTRICTION, PATHOLOGIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; RISK FACTORS;

EID: 77957720103     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.06.017     Document Type: Article

References (30)

1. Department of Health, Executive Yuan, R.O.C. Statistics of causes of death, 2008 2009, Department of Health, Executive Yuan, R.O.C., Taipei, [accessed 30.12.09]. http://www.doh.gov.tw/EN2006/DM/DM2.aspx%3Fnow_fod_list_no=9086%26class_no=390%26level_no=1.
2. Verma S., Wang C.H., Li S.H., et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002, 106:913-919.
3. Norja S., Nuutila L., Karhunen P.J., Goebeler S. C-reactive protein in vulnerable coronary plaques. J Clin Pathol 2007, 60:545-548.
4. Adachi H., Hirai Y., Fujiura Y., et al. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke 2002, 33:2177-2181.
5. Eberhardt R.T., Forgione M.A., Cap A., et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 2000, 106:483-491.
6. Zebrack J.S., Muhlestein J.B., Horne B.D., Anderson J.L. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002, 39:632-637.
7. Durga J., Bots M.L., Schouten E.G., Kok F.J., Verhoef P. Low concentrations of folate, not hyperhomocysteinemia, are associated with carotid intima-media thickness. Atherosclerosis 2005, 179:285-292.
8. Jacobs P.C., Prokop M., van der Graaf Y., et al. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis 2010, 209:455-462.
9. Khera A., de Lemos J.A., Peshock R.M., et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006, 113:38-43.
10. Kullo I.J., Li G., Bielak L.F., Bailey K.R., et al. Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk. Mayo Clin Proc 2006, 81:177-182.
11. Budoff M.J., Achenbach S., Blumenthal R.S., et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association. Circulation 2006, 114:1761-1791.
12. Husmann L., Herzog B.A., Burkhard N., et al. Body physique and heart rate variability determine the occurrence of stair-step artifacts in 64-slice CT coronary angiography with prospective ECG-triggering. Eur Radiol 2009, 19:1698-1703.
13. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995, 92:2157-2162.
14. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975, 51(Suppl. 4):5-40.
15. Leber A.W., Becker A., Knez A., et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol 2006, 47:672-677.
16. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee.
17. Lorenz M.W., Karbstein P., Markus H.S., Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007, 38:1774-1779.
18. Veselka J., Prochazkova S., Duchonova R., et al. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 2002, 13:151-154.
19. Blankenhorn D.H., Curry P.J. The accuracy of arteriography and ultrasound imaging for atherosclerosis measurement: a review. Arch Pathol Lab Med 1982, 106:483-489.
20. Reilly M.P., Wolfe M.L., Localio A.R., Rader D.J. C-reactive protein and coronary artery calcification: the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003, 23:1851-1856.
21. Taniguchi H., Momiyama Y., Fayad Z.A., et al. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am Heart J 2004, 148:137-143.
22. Sarwar A.B., Sarwar A., Rosen B.D., Nasir K. Measuring subclinical atherosclerosis: is homocysteine relevant?. Clin Chem Lab Med 2007, 45:1667-1677.
23. Miller M. An emerging paradigm in atherosclerosis: focus on subclinical disease. Postgrad Med 2009, 121:49-59.
24. Kaptoge S., Di Angelantonio E., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140. Emerging Risk Factors Collaboration.
25. Elliott P., Chambers J.C., Zhang W., et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009, 302:37-48.
26. Shen Y., Qian J.Y., Wang M.H., et al. Quantitative and qualitative assessment of non-obstructive left main coronary artery plaques using 64-multislice computed tomography compared with intravascular ultrasound. CMJ 2010, 123:827-833.
27. Beohar N., Robbins J.D., Cavanaugh B.J., et al. Quantitative assessment of in-stent dimensions: a comparison of 64 and 16 detector multislice computed tomography to intravascular ultrasound. Catheter Cardiovasc Interv 2006, 68:8-10.
28. Choi H.S., Choi B.W., Choe K.O., et al. Pitfalls, artifacts, and remedies in multi-detector row CT coronary angiography. Radiographics 2004, 24:787-800.
29. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.
30. Kuo D.J., Lee Y.C., Huang W.F. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study. Maturitas 2007, 58:259-268.